Not checkedNot checked for notices yet.
First Case Report of a Navajo Indian Patient with Morbihan’s Disease: Insight into Oculoplastic Treatment of a Rare Disease
Lacey Pflibsen, MD, Ana Elizabeth Meza Rochin, BS, Tim Decapite, MD and 1 more
Plastic and Reconstructive Surgery, Global Open · 2020
doi:10.1097/01.gox.0000696036.39137.1d (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Introduction: Morbihan’s disease is classically defined as primarily Caucasian disease of chronic and recurrent erythema and edema of the middle and upper thirds of the face. It is believed to be a rare complication of rosacea. The disease is often difficult to diagnose until more severe signs are visible. Medical management is the primary mode of treatment; however, it is not curative nor very successful. When there is visual impairment, oculoplastic surgeons are consulted for surgical debulking. Case Presentation: We present a 55 year old Navajo male who was referred from Indian Health Service Dermatology (IHSD) clinic to an oculoplastic surgeon in 2012 with a one year history of left upper lid (LUL) swelling. A LUL blepharoplasty was performed with improvement in vision. However, he returned a few years later with contralateral swelling. RUL blepharoplasty was performed and oral prednisone was started with modest improvement. He did not tolerate prednisone due to his diabetes so his treatment was stopped. The following year, he returned with bilateral eyelid swelling. He received subcutaneous triamcinolone eyelid injections yielding satisfactory results of decreased swelling. Despite this treatment, the edema returned after 6 months. Conclusion: This is the first reported case of Morbihan’s disease in the Navajo population. Two other Navajo patients have been diagnosed with Morbihan’s disease at IHSD. Multidisciplinary approach with dermatology and oculoplastic surgery is required for complex medical and surgical management. Future work includes research into genetic predilection of Morbihan’s in the Navajo population and targeted systemic treatment options.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.